Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03239327Unknown
Randomised, open-label trial of misoprostol in neonatal respiratory distress syndrome (NRDS) (2 arms), sponsored by Assiut University. Primary endpoint: Rate of Neonatal Intensive Care Unit admission for neonatal respiratory distress at 24 hours. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03239327.